U.S. FDA approves expanded use of J&J's cancer cell therapy

 The U.S. Food and Drug Administration on Friday allowed the expanded use of Johnson & Johnson and Legend Biotech's Carvykti cell therapy as an earlier treatment for patients with a type of blood cancer.

https://www.marketscreener.com/quote/stock/LEGEND-BIOTECH-CORPORATIO-107863240/news/U-S-FDA-approves-expanded-use-of-J-J-s-cancer-cell-therapy-46377144/